Comparing DS Healthcare Group (DSKX) & The Competition
DS Healthcare Group (NASDAQ: DSKX) is one of 33 publicly-traded companies in the “Personal Products” industry, but how does it contrast to its peers? We will compare DS Healthcare Group to similar businesses based on the strength of its earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.
This table compares DS Healthcare Group and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DS Healthcare Group||-104.81%||N/A||-196.55%|
|DS Healthcare Group Competitors||-46.71%||137.56%||5.16%|
This table compares DS Healthcare Group and its peers gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|DS Healthcare Group||N/A||N/A||-0.02|
|DS Healthcare Group Competitors||$14.48 billion||$2.96 billion||14.37|
DS Healthcare Group’s peers have higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
DS Healthcare Group has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, DS Healthcare Group’s peers have a beta of 1.09, suggesting that their average stock price is 9% more volatile than the S&P 500.
This is a summary of current ratings and price targets for DS Healthcare Group and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DS Healthcare Group||0||0||0||0||N/A|
|DS Healthcare Group Competitors||352||1214||1490||23||2.38|
As a group, “Personal Products” companies have a potential upside of 6.62%. Given DS Healthcare Group’s peers higher possible upside, analysts plainly believe DS Healthcare Group has less favorable growth aspects than its peers.
Insider & Institutional Ownership
8.5% of DS Healthcare Group shares are held by institutional investors. Comparatively, 57.5% of shares of all “Personal Products” companies are held by institutional investors. 19.4% of DS Healthcare Group shares are held by company insiders. Comparatively, 15.4% of shares of all “Personal Products” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
DS Healthcare Group peers beat DS Healthcare Group on 7 of the 8 factors compared.
About DS Healthcare Group
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
Receive News & Ratings for DS Healthcare Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.